Literature DB >> 8386551

Financing and payment reform for primary health care and substance abuse treatment.

R Kunnes1, R Niven, T Gustafson, N Brooks, S M Levin, M Edmunds, J G Trumble, M J Coye.   

Abstract

One of the most controversial areas for health care reform concerns the treatment of alcohol and other drug problems, which account for some of the most rapidly rising costs in the health care sector. There is arguably no other set of conditions that show such variation in accessibility to treatment on the basis of insurance status, present the same degree of difficulty in providing comprehensive care, or challenge as many public and professional assumptions about behavioral, social and economic determinants. The purpose of this article is to discuss some of the financing and coverage barriers to comprehensive treatment for alcohol and other drug abuse; to discuss some innovative mechanisms for providing and financing comprehensive services; and to suggest some directions for public policy to support the development of new practice models that emphasize cost-effectiveness and efficiency of care.

Entities:  

Mesh:

Year:  1993        PMID: 8386551     DOI: 10.1300/J069v12n02_03

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  4 in total

1.  Trends in comprehensive service availability in outpatient drug abuse treatment.

Authors:  Peter D Friedmann; Stephenie C Lemon; Elizabeth M Durkin; Thomas A D'Aunno
Journal:  J Subst Abuse Treat       Date:  2003-01

2.  Clinical practice guidelines: Opportunities and implications.

Authors:  M Edmunds
Journal:  Ann Behav Med       Date:  1996-06

3.  Integrating primary medical care with addiction treatment: a randomized controlled trial.

Authors:  C Weisner; J Mertens; S Parthasarathy; C Moore; Y Lu
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

4.  The case for chronic disease management for addiction.

Authors:  Richard Saitz; Mary Jo Larson; Colleen Labelle; Jessica Richardson; Jeffrey H Samet
Journal:  J Addict Med       Date:  2008-06       Impact factor: 3.702

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.